N. I. Zozulya

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Tadashi Matsushita, Amy D. Shapiro, Aby Abraham et al. · New England Journal of Medicine · 2023 · 91 citations · Full text

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin et al. · Haemophilia · 2015 · 56 citations · Full text

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients

Toshko Lissitchkov, Bella Madan, Claudia Djambas Khayat et al. · Journal of Thrombosis and Haemostasis · 2019 · 34 citations · Full text

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial

Toshko Lissitchkov, Bella Madan, Claudia Djambas Khayat et al. · Transfusion · 2017 · 24 citations · Full text

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study

Jack Spira, Olga P Plyushch, N. I. Zozulya et al. · Haemophilia · 2010 · 23 citations

Immunohematology, Pharmacotherapy, Factor Viia +16